A number of NF-kB inhibitors have been demonstrated to induce anti-proliferative and anti-apoptotic effects against thyroid cancer cells, and various anticancer compounds exert their effects by blocking this pathway [10,45,46,47]. Here, NFKB1 is linked to thyroid gland carcinoma.